According to Zoetis's latest financial reports the company's current earnings (TTM) are $2.74 B. In 2021 the company made an earning of $2.48 B an increase over its 2020 earnings that were of $1.99 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | $2.52 B | 1.61% |
2021 | $2.48 B | 24.65% |
2020 | $1.99 B | 10.83% |
2019 | $1.80 B | 6.57% |
2018 | $1.69 B | 10.82% |
2017 | $1.52 B | 24.19% |
2016 | $1.22 B | 125.32% |
2015 | $0.54 B | -33.54% |
2014 | $0.82 B | 18.84% |
2013 | $0.69 B | -2.82% |
2012 | $0.71 B | 80.2% |
2011 | $0.39 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $28.95 B | 953.75% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $7.06 B | 157.26% | ๐บ๐ธ USA |
![]() Sanofi SNY | $9.82 B | 257.67% | ๐ซ๐ท France |
![]() Merck MRK | $16.60 B | 504.18% | ๐บ๐ธ USA |
![]() Phibro Animal Health
PAHC | $0.08 B | -96.80% | ๐บ๐ธ USA |
![]() Kindred Biosciences
KIN | -$0.04 B | -101.44% | ๐บ๐ธ USA |
![]() Heska Corporation
HSKA | -$0.02 B | -100.43% | ๐บ๐ธ USA |